방사선종양학

본문글자크기
  • 2017년 10월호
    [Eur J Surg Oncol.] Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.

    이화의대 / 권진이, 김규보*

  • 출처
    Eur J Surg Oncol.
  • 등재일
    2017 Sep
  • 저널이슈번호
    43(9):1690-1696. doi: 10.1016/j.ejso.2017.05.024. Epub 2017 Jun 15.
  • 내용

    바로가기  >


     

    전이 림프절 비율 (LNR)과 전이 림프절의 개수 (MLN)에 따른 전체 생존율 (Overall survival)과 무국소 재발 생존율 (Locoregional failure-free survival)

    Abstract

    PURPOSE:

    Attempts have been made to revise the nodal stage due to simplicity of current N staging system in ampullary adenocarcinoma. However, because of the disease rarity, there have only been a few studies assessing the prognostic impact of lymph node (LN) parameters.


    METHODS:

    We retrospectively analyzed 120 patients who underwent radical resection followed by adjuvant chemoradiotherapy for ampullary adenocarcinoma. The effect of LN parameters (number of total harvest LNs, number of metastatic LN (MLN), lymph node ratio (LNR), and log odds of positive LNs (LODDS)) on overall survival (OS), locoregional relapse-free survival (LRFS) and distant metastasis-free survival were evaluated. Cutoff points of MLN, LNR and LODDs were determined using maximal χ2 method.

     

    RESULTS:

    Fifty-seven patients (48%) were staged as pN1 and their survival was not significantly decreased compared with pN0 patients. There was also no significant difference between patients with MLN 0 vs. 1. In univariate analyses, MLN (0-1 vs. ≥2), LNR (≤17% vs. >17%) and perineural invasion were common prognosticators for OS and LRFS. Distant metastasis-free survival was not influenced by LN status. In addition, multivariate analysis revealed that among the LN parameters, LNR was able to independently predict both OS and LRFS.

     

    CONCLUSIONS:

    LNR performs better than other LN related parameters for predicting survival. After radical resection followed by adjuvant treatment, survival of patients with one positive LN does not seem to differ from patients without LN metastasis.

     

    Author information

    Kwon J1, Kim K2, Chie EK3, Kim BH3, Jang JY4, Kim SW4, Oh DY5, Bang YJ5.

    Department of Radiation Oncology, Seoul National University College of Medicine, Daehak-ro 101, Jongno-gu, Seoul, South Korea; Department of Radiation Oncology, Chungnam National University Hospital, Munhwaro 282, Jungku, Daejeon, South Korea.

    Department of Radiation Oncology, Ewha Womans University School of Medicine, Anyangcheon-ro, Yangcheon-gu, Seoul, South Korea. Electronic address: kyubokim.ro@gmail.com.

    Department of Radiation Oncology, Seoul National University College of Medicine, Daehak-ro 101, Jongno-gu, Seoul, South Korea.

    Department of Surgery, Seoul National University College of Medicine, Daehak-ro 101, Jongno-gu, Seoul, South Korea.

    Department of Internal Medicine, Seoul National University College of Medicine, Daehak-ro 101, Jongno-gu, Seoul, South Korea.

     

  • 키워드
    Ampullary adenocarcinoma; Lymph node metastasis; Lymph node ratio; Number of metastatic lymph node​
  • 연구소개
    본 연구는 근치적 절제술과 수술 후 항암화학방사선요법을 시행받은 바터팽대부암 120명의 환자를 대상으로 림프절 전이 지표를 분석한 연구입니다. AJCC 7판의 림프절 병기는 단순히 림프절 전이 유무로만 나누고 있으나, 전이 유무나 전이 림프절의 개수만 고려하는 것보다 전이 림프절 비율 (LNR)이 본 환자군에서 전체 생존율과 국소 재발률을 좀 더 잘 예측하는 것을 확인할 수 있었습니다. 또한, 근치적 절제술과 수술 후 항암화학방사선요법을 완료한 경우, 림프절 전이가 동반되지 않은 환자와 단지 하나의 림프절 전이만 발견된 환자의 예후에 차이가 없음을 확인하였습니다. 본 연구는 유병률이 낮은 바터팽대부암에서 비교적 균일한 집단(수술 후 항암화학방사선요법을 모두 시행한 환자군)을 대상으로, 가장 많은 환자수를 포함하여 분석한 연구로서 그 가치가 있겠습니다.
  • 덧글달기
    덧글달기
       IP : 3.12.162.179

    등록